Hycor Biomedical and Beijing NaGene Diagnosis together supply direct RT-PCR kits for 2019-nCoV

Updated: Feb 19

May 01, 2020 – KASSEL, GERMANY - Hycor Biomedical, a leading manufacturer of in vitro diagnostics products for allergy and autoimmune testing, together with Beijing NaGene Diagnosis Co,. Ltd, a highly innovative company dedicated primarily in research and development, production, and sales of breakthrough molecular diagnostic technology, are now together on a mission of saving lives in different coronavirus outbreak areas with NaGene’s 2019-nCoV direct RT-PCR kit.

The innovative technique used in NaGene's direct RT-PCR kit is quick and simple as it does not need RNA extraction and purification of nucleic acids enabling the laboratories in being more efficient and to perform more tests in less time.

Direct Multiple Real-Time PCR kit for 2019-nCoV detection is not available for sale in the U.S. Product availability may differ in different countries, please contact HYCOR representative at info@hycorbiomedical.com